Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 203,783 | 300,694 | 191,193 | 188,646 | 105,019 |
| Marketable Securities | 784,866 | 814,055 | 610,831 | 659,422 | 826,232 |
| Receivables | 134,476 | 113,285 | 79,231 | 61,428 | 53,822 |
| Inventories | 74,841 | 69,317 | 63,497 | 55,241 | 34,068 |
| TOTAL | $1,245,770 | $1,346,680 | $1,003,356 | $987,979 | $1,032,927 |
| Non-Current Assets | |||||
| PPE Net | 1,499 | 2,913 | 1,615 | 1,901 | 2,190 |
| Intangibles | 7,381 | 7,477 | 4,548 | 4,639 | 4,729 |
| Other Non-Current Assets | 4,939 | 5,387 | 5,862 | 2,110 | 2,401 |
| TOTAL | $13,819 | $15,777 | $12,025 | $8,650 | $9,320 |
| Total Assets | $1,259,589 | $1,362,457 | $1,015,381 | $996,629 | $1,042,247 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,878 | 44,941 | 37,975 | 42,056 | 43,599 |
| Accrued Expenses | 260,392 | 345,382 | 157,479 | 124,165 | 124,695 |
| TOTAL | $310,288 | $391,406 | $196,503 | $167,237 | $169,277 |
| Non-Current Liabilities | |||||
| Long Term Debt | 339,881 | 339,753 | 118,376 | 118,005 | 117,569 |
| Other Non-Current Liabilities | 6,731 | 5,566 | 4,524 | 750 | 1,018 |
| TOTAL | $346,612 | $345,319 | $122,900 | $118,755 | $118,587 |
| Total Liabilities | $656,900 | $736,725 | $319,403 | $285,992 | $287,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,940 | 22,711 | 22,289 | 22,203 | 22,080 |
| Common Shares | 2 | 2 | N/A | 2 | 2 |
| Retained earnings | -2,090,466 | -2,031,891 | -1,917,701 | -1,875,420 | -1,802,182 |
| Other shareholders' equity | 873 | 1,068 | 1,113 | 389 | 468 |
| TOTAL | $602,689 | $625,732 | $695,978 | $710,637 | $754,383 |
| Total Liabilities And Equity | $1,259,589 | $1,362,457 | $1,015,381 | $996,629 | $1,042,247 |